Roxadustat and the Interpretation of Non-Inferiority
freecme000
Published on Nov 29, 2022
CLICK ON LINK BELOW
https://www.asn-online.org/media/podcast/JASN/2022_04_11_JASN2021050681.mp3
Dr. Josie Briggs, discusses a non-inferiority trial on Roxadustat in dialysis patients and explains the interpretation of the finding that roxadustat is non-inferior to epoetin alpha.
Category
Add to
Please Sign In or Create Account to use this feature!
Flag Podcast
Please Sign In or Create Account to use this feature!
Rate podcast
Please Sign In or Create Account to use this feature!
Rate podcast
Please Sign In or Create Account to use this feature!
Up next
Autoplay
Autoplay
Recommended
-
Watch Later
00:04Acute Interstitial Nephritis and Checkpoint Inhibitor Therapy
126 views 1363 days ago -
Watch Later
00:04Venous Thrombotic Events in ANCA-Associated Vasculitis: Incidence and Risk Factors
92 views 1363 days ago -
Watch Later
00:04 -
Watch Later
00:04 -
Watch Later
00:04New Vancomycin Dosing Guidelines for Hemodialysis Patients: Rationale, Caveats, and Limitations
185 views 1363 days ago -
Watch Later
00:04 -
Watch Later
![Trajectories of Serum Sodium on In-Hospital and 1-Year Survival among Hospitalized Patients​]()
00:04Trajectories of Serum Sodium on In-Hospital and 1-Year Survival among Hospitalized Patients​
115 views 1349 days ago -
Watch Later
![Addressing CKD Progression and Hazards of Intradialytic Hypotension]()
00:04Addressing CKD Progression and Hazards of Intradialytic Hypotension
135 views 1068 days ago
